1. Home
  2. HYPR vs NTRB Comparison

HYPR vs NTRB Comparison

Compare HYPR & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyperfine Inc.

HYPR

Hyperfine Inc.

HOLD

Current Price

$1.00

Market Cap

104.0M

Sector

Health Care

ML Signal

HOLD

Logo Nutriband Inc.

NTRB

Nutriband Inc.

HOLD

Current Price

$4.95

Market Cap

71.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYPR
NTRB
Founded
2014
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
71.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HYPR
NTRB
Price
$1.00
$4.95
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$1.28
$13.00
AVG Volume (30 Days)
610.8K
23.4K
Earning Date
11-13-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,591,000.00
$2,278,321.00
Revenue This Year
$5.17
$30.17
Revenue Next Year
$35.44
$3,394.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.69
52 Week Low
$0.53
$3.72
52 Week High
$2.22
$11.78

Technical Indicators

Market Signals
Indicator
HYPR
NTRB
Relative Strength Index (RSI) 43.62 45.12
Support Level $0.85 $4.60
Resistance Level $1.10 $5.45
Average True Range (ATR) 0.08 0.37
MACD 0.01 0.10
Stochastic Oscillator 44.59 64.79

Price Performance

Historical Comparison
HYPR
NTRB

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: